Notis Mc Conarty Edward Bristol Myers Squibb CO Transaction History
Notis Mc Conarty Edward
- $252 Million
- Q2 2024
A detailed history of Notis Mc Conarty Edward transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Notis Mc Conarty Edward holds 9,335 shares of BMY stock, worth $453,494. This represents 0.15% of its overall portfolio holdings.
Number of Shares
9,335
Previous 10,135
7.89%
Holding current value
$453,494
Previous $549,000
29.51%
% of portfolio
0.15%
Previous 0.22%
Shares
20 transactions
Others Institutions Holding BMY
# of Institutions
2,400Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.06 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.71 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.44 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.63 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$2.87 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $103B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...